1
|
Soares PI, Ferreira IM, Igreja RA, Novo CM
and Borges JP: Application of hyperthermia for cancer treatment:
recent patents review. Recent Pat Anticancer Drug Discov. 7:64–73.
2012.
|
2
|
Wust P, Hildebrandt B, Sreenivasa G, et
al: Hyperthermia in combined treatment of cancer. Lancet Oncol.
3:487–497. 2002.
|
3
|
Falk MH and Issels RD: Hyperthermia in
oncology. Int J Hyperthermia. 17:1–18. 2001.
|
4
|
Ross MI: Current status of hyperthermic
limb perfusion for in-transit melanoma. Int J Hyperthermia.
24:205–217. 2008.
|
5
|
Pennacchioli E, Fiore M and Gronchi A:
Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.
Expert Rev Anticancer Ther. 9:199–210. 2009.
|
6
|
Brewer WG Jr and Turrel JM: Radiotherapy
and hyperthermia in the treatment of fibrosarcomas in the dog. J Am
Vet Med Assoc. 181:146–150. 1982.
|
7
|
Page RL and Thrall DE: Clinical
indications and applications of radiotherapy and hyperthermia in
veterinary oncology. Vet Clin North Am Small Anim Pract.
20:1075–1092. 1990.
|
8
|
Gillette EL: Hyperthermia effects in
animals with spontaneous tumors. Natl Cancer Inst Monogr.
61:361–364. 1982.
|
9
|
Grier RL, Brewer WG Jr and Theilen GH:
Hyperthermic treatment of superficial tumors in cats and dogs. J Am
Vet Med Assoc. 177:227–233. 1980.
|
10
|
Stojkovic R and Radacic M: Cell killing of
melanoma B16 in vivo by hyperthermia and cytotoxins. Int J
Hyperthermia. 18:62–71. 2002.
|
11
|
Ito A, Fujioka M, Yoshida T, et al:
4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for
combination therapy of hyperthermia with chemotherapy against
malignant melanoma. Cancer Sci. 98:424–430. 2007.
|
12
|
Haen SP, Pereira PL, Salih HR, Rammensee
HG and Gouttefangeas C: More than just tumor destruction:
immunomodulation by thermal ablation of cancer. Clin Dev Immunol.
2011:1602502011.
|
13
|
Takagi H, Azuma K, Tsuka T, Imagawa T,
Osaki T and Okamoto Y: Anti-tumor effects of high-temperature
hyperthermia on a glioma rat model. Oncol Lett. 7:1007–1010.
2014.
|
14
|
Baisi A, De Simone M, Raveglia F and
Cioffi U: Thermal ablation in the treatment of lung cancer: present
and future. Eur J Cardiothorac Surg. 43:683–686. 2013.
|
15
|
Diederich CJ: Thermal ablation and
high-temperature thermal therapy: overview of technology and
clinical implementation. Int J Hyperthermia. 21:745–753. 2005.
|
16
|
Roti Roti JL: Cellular responses to
hyperthermia (40–46 degrees C): cell killing and molecular events.
Int J Hyperthermia. 24:3–15. 2008.
|
17
|
den Brok MH, Sutmuller RP, van der Voort
R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor
ablation creates an antigen source for the generation of antitumor
immunity. Cancer Res. 64:4024–4029. 2004.
|
18
|
Baronzio G, Gramaglia A and Fiorentini G:
Hyperthermia and immunity. A brief overview. In Vivo. 20:689–695.
2006.
|
19
|
Zerbini A, Pilli M, Penna A, et al:
Radiofrequency thermal ablation of hepatocellular carcinoma liver
nodules can activate and enhance tumor-specific T-cell responses.
Cancer Res. 66:1139–1146. 2006.
|
20
|
Mukhopadhaya A, Mendecki J, Dong X, et al:
Localized hyperthermia combined with intratumoral dendritic cells
induces systemic antitumor immunity. Cancer Res. 67:7798–7806.
2007.
|
21
|
Zhang HG, Mehta K, Cohen P and Guha C:
Hyperthermia on immune regulation: a temperature’s story. Cancer
Lett. 271:191–204. 2008.
|
22
|
Moroz P, Jones SK and Gray BN:
Magnetically mediated hyperthermia: current status and future
directions. Int J Hyperthermia. 18:267–284. 2002.
|
23
|
Wiggermann P, Puls R, Vasilj A, Sieroń D,
Schreyer AG, Jung EM, Wawrzynek W and Stroszczynski C: Thermal
ablation of unresectable liver tumors: factors associated with
partial ablation and the impact on long-term survival. Med Sci
Monit. 18:CR88–CR92. 2012.
|